← Leaderboards
Margaret J Koziel
Beth Israel Deaconess Medical Center
$5,996,609
Attributed
$5,996,609
Total exposure
8
Grants
6
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $1.5M · FY2005–20$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
Funding mix
By agency
NIH$7,501,242 · 9
By mechanism
R01$2,645,102 · 2
U19$2,521,856 · 2
U54$1,788,284 · 2
R29$253,400 · 1
R21$207,600 · 1
R03$85,000 · 1
Top collaborators
No co-investigators on record.
Most similar at Beth Israel Deaconess Medical Center
Same institution · by research overlap
- Michael Steer$6,517,536
- Detlef Schuppan$2,333,301
- Nira Pollock$9,552,528
- John Dashe$775,664
- Mark A Exley$2,283,685
Others in their field
Top investigators on “Hepatitis C Virus”
- Constance Ann Benson · University Of California, San Diego$150,079,712
- Sharon A Nachman · Johns Hopkins University$91,575,784
- Peter B. Gilbert · Fred Hutchinson Cancer Center$77,122,577
- Robert Turner Schooley · University Of Colorado Denver$45,719,253
- Charles R Rinaldo · University Of Pittsburgh At Pittsburgh$44,694,148
- Charles M. Rice · Rockefeller University$42,549,577
Research focus
Hepatitis C VirusHepatitis CCytokinePatient OrientedPoint Of CareLiverPilot ProjectsCare Technology PointsDiagnosisPrototypeTissue /Cell CultureServicesResourcesChronic Disease /DisorderIndustry PartnerVirus ReplicationInflammationImmune ResponsePathologic ProcessClinical ResearchAcuteBloodLiver DiseasesLaboratory Mouse
Grant awards (26)
Admin Core: The Center for Advancing Point of Care Technologies in Heart, Lung, Blood and Sleep Diseases$399,999
U54 · FY2020 · HL · contact PI
Clinical Trans Valid: The Center for Advancing Point of Care Technologies in Heart, Lung, Blood and Sleep Diseases$173,191
U54 · FY2020 · HL · contact PI
Admin Core: The Center for Advancing Point of Care Technologies in Heart, Lung, Blood and Sleep Diseases$402,289
U54 · FY2019 · HL · contact PI
Clinical Trans Valid: The Center for Advancing Point of Care Technologies in Heart, Lung, Blood and Sleep Diseases$172,530
U54 · FY2019 · HL · contact PI
Admin Core: The Center for Advancing Point of Care Technologies in Heart, Lung, Blood and Sleep Diseases$416,205
U54 · FY2018 · HL · contact PI
Clinical Trans Valid: The Center for Advancing Point of Care Technologies in Heart, Lung, Blood and Sleep Diseases$224,070
U54 · FY2018 · HL · contact PI
Immunologic Correlates of Liver Disease Progression$153,951
U19 · FY2009 · AI · contact PI
Immunologic Correlates of Liver Disease Progression$154,065
U19 · FY2008 · AI · contact PI
Determinants of Liver Injury in Chronic Hepatitis C Virus Infection$568,906
U19 · FY2007 · AI · contact PI
Immunologic Correlates of Liver Disease Progression$253,873
U19 · FY2007 · AI · contact PI
Impact of Opiates on Cellular Immune Responses in HIV/HCV Infection$85,000
R03 · FY2007 · DA · contact PI
Determinants of Liver Injury in Chronic HCV Infection$585,720
U19 · FY2006 · AI · contact PI
T Lymphocyte Apoptosis in Hepatitis C Persistence$370,094
R01 · FY2006 · AI · contact PI
Immunologic Correlates of Liver Disease Progression$270,221
U19 · FY2006 · AI · contact PI
Natural Killer T Cells in an Animal Model of Hepatitis C$249,008
R01 · FY2006 · AI · contact PI
T Lymphocyte Apoptosis in Hepatitis C Persistence$379,000
R01 · FY2005 · AI
Determinants of Liver Injury in Chronic HCV Infection$350,007
U19 · FY2005 · AI
Natural Killer T Cells in an Animal Model of Hepatitis C$255,000
R01 · FY2005 · AI
Immunologic Correlates of Liver Disease Progression$185,113
U19 · FY2005 · AI
T Lymphocyte Apoptosis in Hepatitis C Persistence$379,000
R01 · FY2004 · AI
Natural Killer T Cells in an Animal Model of Hepatitis C$255,000
R01 · FY2004 · AI
T Lymphocyte Apoptosis in Hepatitis C Persistence$379,000
R01 · FY2003 · AI
Natural Killer T Cells in an animal model of hepatitis C$207,600
R21 · FY2003 · AI
T Lymphocyte Apoptosis in Hepatitis C Persistence$379,000
R01 · FY2002 · AI
IMMUNITY TO HEPATITIS C IN LIVER TRANSPLANT RECIPIENTS$126,700
R29 · FY2001 · AI
IMMUNITY TO HEPATITIS C IN LIVER TRANSPLANT RECIPIENTS$126,700
R29 · FY2000 · AI